penpulimab,pembrolizumab
merck,akesobio,sino biopharmaceuticals
['pembro']
 no point in talking about trials vs chemo alone anymore. they're unethical: only way to do them is to capitalize on care in china being grossly substandard outside of trials. unless a new io agent is available at 1/2 cost of pembro, no point in even acknowledging them, imo.
Med Onc,@CityofHope; VP Netwk Strategy AccessHope, Founder,@CancerGRACE; Web Ed,@JAMAOnc; Author/Ed, @UptoDate

Telemed/digital med fan. 
Disclosures @ website